A human endothelial cell-based recycling assay for screening of FcRn targeted molecules
The development of IgG and albumin-based therapeutics with increased half-lives needs more efficient screening procedures. Here the authors report a human endothelial cell-based recycling assay enabling screening of IgG and albumin variants without chemical labelling and prior to animal testing.
Guardado en:
Autores principales: | Algirdas Grevys, Jeannette Nilsen, Kine M. K. Sand, Muluneh B. Daba, Inger Øynebråten, Malin Bern, Martin B. McAdam, Stian Foss, Tilman Schlothauer, Terje E. Michaelsen, Gregory J. Christianson, Derry C. Roopenian, Richard S. Blumberg, Inger Sandlie, Jan Terje Andersen |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/99bc76e2016a473a870d99a7c561cd47 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Programmable half-life and anti-tumour effects of bispecific T-cell engager-albumin fusions with tuned FcRn affinity
por: Ole A. Mandrup, et al.
Publicado: (2021) -
Human cytomegalovirus evades antibody-mediated immunity through endoplasmic reticulum-associated degradation of the FcRn receptor
por: Xiaoyang Liu, et al.
Publicado: (2019) -
The Neonatal Fc receptor (FcRn) enhances human immunodeficiency virus type 1 (HIV-1) transcytosis across epithelial cells.
por: Sandeep Gupta, et al.
Publicado: (2013) -
Surgical site infections after deep brain stimulation surgery: frequency, characteristics and management in a 10-year period.
por: Silje Bjerknes, et al.
Publicado: (2014) -
The Immune Landscape of Human Primary Lung Tumors Is Th2 Skewed
por: Astri Frafjord, et al.
Publicado: (2021)